Silica Manufacturer in India: Key Producers, Product Ranges and Export Capabilities

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Why Is Silicon Dioxide a Covalent Network Solid? Structure and Properties Explained
  • Keywords: silica MSDS
  • Published: 2026-11-20 11:20:57
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
The unique properties of MSNs make it greatly superior for the construction of multifunctional nanocomposites and drug delivery system. Different therapeutic nanoplatforms obtained through the careful design of MSNs have revealed promising potential in the field of targeted disease therapy. Current applications of MSNs include tumor therapy, 367, 368, 369 anti-infection therapy (bacteria and virus), 370, 371, 372, 373 anti-oxidant/anti-inflammatory therapy (Alzheimer's disease, acute kidney injury, etc.), 374, 375, 376 and metabolic diseases treatment (diabetes, osteoporosis, fatty liver, etc) 377, 378, 379, 380 (Fig. 7 ). In general, the targeted therapeutic characteristics of MSNs can be reflected in the following aspects: (1) Loading chemotherapy drugs or other drugs with toxic side influences, so that they can be released in a controlled manner by MSNs at the targeted sites to prevent their premature release. (2) Selective enrichment at the lesion sites through passive targeting or active targeting, resulting in the higher therapeutic efficacy. (3) Use the MSNs matrix to develop a non-invasive, spatial and temporal controllable targeted therapeutic plan, consequently to overcome the limitations and defects of conventional clinical treatment modalities. To date, the emerging targeted therapeutic modalities developed based on MSNs include dynamic therapy such as photodynamic, sonodynamic and chemodynamic therapies, thermal ablation therapy such as photothermal therapy and magnetic thermotherapy, enzyme-like catalytic therapy, immunotherapy, gene therapy, and others. Meanwhile, the integration of various therapeutic modalities on a single MSNs is expected to enhance the therapeutic efficacy synergistically (Fig. 7 ). In this part, we will discuss MSNs-based therapeutic modalities.

High Purity Silica: Purity Levels (4N–6N), Specifications and Applications

Silica Storage Conditions: How to Store Silica to Prevent Moisture and Caking
Fumed Silica CAS 112945-52-5: Identification, Properties and Safety Data
Quartz CAS 14808-60-7: Identification, Hazards and Regulatory Information
Kempen, P. J. et al. Theranostic mesoporous silica nanoparticles biodegrade after pro-survival drug delivery and ultrasound/magnetic resonance imaging of stem cells. Theranostics 5, 631 (2015). Piece CAS PubMed Central PubMed Google Scholar
Silica for Beer Clarification: How Silica Gel Improves Beer Stability

Aerosil 200: Specifications, Applications and Equivalent Fumed Silica Grades

What is silica (SiO₂)?

precipitated silica market

What is the difference between fumed silica and precipitated silica?

pharmaceutical grade silica Zhou, M. et al. Cancer cell membrane camouflaged semi‐yolk@spiky‐shell nanomotor for enhanced cell adhesion and synergistic therapy. Tiny 16, 2003834 (2020). Article CAS Google Scholar

What drives silica raw material prices?

fumed silica brands Targeted delivery tactics are generally divided into two categories: passive targeting and active targeting. Passive targeting relies on the pathological qualities of the disease microenvironment and the nature of the drug delivery system itself, which allows the drug to effectively accumulate at the lesion site of disease. The most well-known passive targeting is the EPR effect of tumor, which refers to the phenomenon that some particles with particular size (20-200 nm) penetrate more without difficulty into tumor tissue and remain there for a long time when compared to normal tissue. 316, 317 Therefore, controlling the size of MSNs to a fitting range will facilitate their enrichment in the tumor sites. However, it has also been highlighted that the passive targeting strategy relying on the EPR effect can attain only 0.7% of the injected NPs enrichment in solid tumors, 318 which will not be handy for the clinical translation of nanotechnology. In contrast, active targeting relies on the active recognition between the molecules on the NPs surface and the specific molecules or proteins in the illness microenvironment, which is also referred to as ligand-receptor specific binding. 319 The active targeting shows a higher drug delivery efficiency compared to passive targeting. 320 Targeted ligands, such as proteins, antibodies, peptides, nucleic acids and chemical tiny molecules, can be modified on the surface of MSNs, and the modified MSNs are capable of selectively aggregating at the lesion site based on the powerful affinity between the targeted ligands and the particular receptors overexpressed in the sickness microenvironment. 321, 322, 323, 324 For instance, compared to mature vascular endothelial cells, tumor neovascular endothelial cells are highly expressed in an array of proteins, such as integrins, transmembrane glycoproteins and aminopeptidase N. Molecules that recognize these highly expressed proteins can be used for neovascular-based targeted drug delivery. A standard example is that arginylglycylaspartic acid (RGD)-modified MSNs can selectively bind integrin α ν β 3 receptor and hence be applied to target tumor neovascularization. 325

Cite this article: Silica Raw Materials News. "Feed Grade Silica: Specifications and Uses as a Carrier and Flow Agent in Animal Feed ." Published 2026-11-20 11:20:57. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.